Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

Cassipa (buprenorphine and naloxone)

FDA Approves New Treatment for Opioid Dependence

The sublingual buprenorphine and naloxone combo should be part of a complete treatment plan
Four more online networks that operate 21 websites illegally selling potentially dangerous

FDA Warning Letters Target Illegal Online Sales of Opioids

Medications may be counterfeit, contaminated, expired, or otherwise unsafe
Hundreds of Dr. King's water-based homeopathic drugs for children

FDA: Hundreds of Human, Pet Homeopathy Products Recalled

King Bio recalls number of water-based products due to high levels of microbial contamination
Oxervate (cenegermin) has been approved by the U.S. Food and Drug Administration to treat neurotrophic keratitis

FDA Approves First Drug for Neurotrophic Keratitis

Oxervate, a topical eye drop, led to complete corneal healing among 70 percent of study participants
Potentially poisonous electronic cigarette liquid made by 17 different manufacturers comes in packaging that strongly resembles that of candies

FDA Bans E-Cig Liquid Products That Look Like Snacks, Candies

Labels and ads for the nicotine-containing e-liquids were false or misleading, and potentially dangerous
The first generic version of the EpiPen has been approved by the U.S. Food and Drug Administration

FDA Approves First Generic EpiPen

Approval will address both rising costs and shortages of epinephrine
A brain stimulation device to treat obsessive-compulsive disorder has received approval for marketing by the U.S. Food and Drug Administration.

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines
Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma.

FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma

Drug approved to treat relapsed or refractory mycosis fungoides and Sézary syndrome
Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare adrenal gland tumors (pheochromocytoma or paraganglioma) that can't be surgically removed and have spread beyond the original site.

FDA Approves Azedra for Rare Adrenal Tumors

First systemic treatment for patients who experience tumor-related symptoms such as hypertension
A magnetic system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy has been approved by the U.S. Food and Drug Administration.

FDA Approves Magnetic System for Guiding Lymph Node Biopsies

Sentimag System uses magnetic detection to identify sentinel lymph nodes for surgical removal